Please login to the form below

Not currently logged in
Email:
Password:

Egalet appoints Stan Musial as CFO

Joins US pharma company after a two-year spell as a start-up consultant

Stan Musial has joined US pharma company Egalet as chief financial officer having spent the past two years as an independent consultant for start-up businesses.

His most recent in-house role was as chief financial officer at Prism Pharmaceuticals, where he served from 2005 to 2011 before its sale to Baxter Healthcare.

Prior to joining Prism, Musial held the position of VP, finance, and chief financial officer for Strategic Diagnostics.

Egalet is a company that specialises in developing abuse-deterrent medication via a platform that prevents easy extraction and deters abuse of drugs through known routes, such as chewing, snorting, and injecting.

The company's president and chief executive Bob Radie said: "The addition of Stan to the management team comes at a critical time as the most advanced products in Egalet's pipeline of abuse-deterrent opioids are nearing phase III.

"Stan's finance experience will be invaluable as we move our pipeline through development and ultimately to the commercial market."

10th May 2013

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Spirit, an OPEN Health Company

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...